Great rundown on the position(s) of Merck, BMS and Roche with respect to the FDA review taking place tonight.
my interpretation (fwiw dyor) is that it will bring significant pressure onto the owners of the leading immuno oncolytic productscts to show value and improved OSR, to maintain their market standing and revenues...
a good read if you want to be familiar with the competition in the Monoclonal antibody space.
enjoy, :-)
://www.fiercepharma.com/pharma/merck-bristol-myers-roche-to-face-fda-scrutiny-for-pd-1-l1-accelerated-approvals-at-adcom-aWhat are Merck, Bristol Myers and Roche planning for the big FDA cancer approval
review? Here's our rundown
apo!
https
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-1062
-
- There are more pages in this discussion • 14,801 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $279.2K | 5.733M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
94 | 12992150 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 1795056 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
93 | 12942150 | 0.048 |
44 | 4009024 | 0.047 |
33 | 3946479 | 0.046 |
48 | 4998765 | 0.045 |
9 | 899955 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1795056 | 6 |
0.050 | 1199729 | 8 |
0.051 | 1430603 | 8 |
0.052 | 1994270 | 12 |
0.053 | 2727411 | 21 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |